Litcius/Paper detail

Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors

Eslam M.H. Ali, Rania Farag A. El‐Telbany, Mohammed S. Abdel‐Maksoud, Usama M. Ammar, Karim I. Mersal, Seyed–Omar Zaraei, Mohammed I. El‐Gamal, Se-In Choi, Kyung‐Tae Lee, Hee-Kwon Kim, Kwan H. Lee, Chang‐Hyun Oh

2021European Journal of Medicinal Chemistry29 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryIC50KinaseDocking (animal)p38 mitogen-activated protein kinasesPyrimidineCytotoxicityLead compoundBiochemistryProtein kinase ASerineEnzymePharmacologyIn vitroBiologyNursingMedicineMelanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors | Litcius